The extraordinary general meeting in Prolight Diagnostics AB (publ) on 19 November 2025, resolved on a reverse share split of 1:100, whereby one hundred (100) existing shares will be consolidated into one (1) new share. The extraordinary general meeting authorised the board of directors to determine the record date for the reverse share split. The board of directors has, pursuant to the authorisation, resolved that the record date for the reverse share split shall be 11 December 2025.

Timeline for the reverse share split:

Shareholders are not required to take any action to participate in the reverse share split. Following the reverse share split, Prolight’s shares will change ISIN code. The new ISIN code SE0027099656 will apply from 10 December 2025.

A shareholder who on the record date does not hold a number of shares that is evenly divisible by 100 will receive, from Mangold Fondkommission AB (the guarantor), free of charge such number of shares (1–99 shares) that the shareholder's holding, after addition of provided shares, is evenly divisible by 100 (so-called rounding up). The provision of such equalization shares will be provided through Euroclear Sweden AB, without requiring any further action from shareholders.
Following the reverse share split, the number of shares in the company will amount to 12,044,782, which represents a quota value of SEK 10 per share.